NLM Logo

R-FCM protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
R-FCM protocol
Unique ID
C518738
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C518738
Registry Number
0
Previous Indexing
Antibodies, Monoclonal (2007-2010)
Heading Mapped to
*Rituximab
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Mitoxantrone
Vidarabine / *analogs & derivatives
Frequency
4
Note
chemotherapy protocol consisting of rituximab, fludarabine, cyclophosphamide, and mitoxanthrone for treatment of mantle cell lymphoma
Source
Leukemia 2007 Mar;21(3):524-8
Date of Entry
2007/04/11
Revision Date
2021/08/09
R-FCM protocol Preferred
page delivered in 0.003s